“This is a great year for us and for our patients. The National Plan for Rare Diseases has been launched. We've been waiting for this for over 10 years. Thanks to the support of AOTMiT and the Ministry of Health and the National Health Fund, therapeutic programs for our patients are not only continued, but also new ones appear, including in SMA or Duchenne's disease - said in an interview with Medexpress prof. Zbigniew Żuber, pediatrician and rheumatologist, head of the 2nd Clinical Ward for Older Children with Neurological and Rheumatology subdivisions in Krakow, summarizing the ending year.
Prof. Zbigniew Żuber sums up 2022 in the care of patients with rare diseases
Published Dec. 19, 2022 11:25
